CPHI 2025 live: Roquette’s global merger boosts nutraceutical and excipient portfolio
29 Oct 2025 | Roquette
On the showroom floor of CPHI 2025, Udo Losehand, head of global technical developers at Roquette, highlights how the company’s recent integration with IFF Pharma Solutions and Qualicaps has expanded its excipient and capsule solutions for the nutraceutical sector. Combining three complementary portfolios, the unified offering enhances application support and co-development capabilities through global labs. Losehand also talks about innovations in taste masking, texture modulation, and cost-efficient manufacturing, including directly compressible ingredients and co-processed excipients.
Upcoming webinars

The science of HMOs – A novonesis webinar featuring new clinical findings and ESPGHAN highlights
Novonesis

From boosters to companions: GLP-1 in Food, Beverages and Supplements
Rousselot

Top Nutrition Trends 2027
Nutrition Insight















